SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-22-009469
Filing Date
2022-02-25
Accepted
2022-02-25 16:10:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-3 ea156149-f3a2_tizianalife.htm F-3/A 273159
2 OPINION OF CONYERS DILL & PEARMAN LIMITED ea156149ex5-1_tizianalife.htm EX-5.1 17379
3 CONSENT OF MAZARS LLP ea156149ex23-1_tizianalife.htm EX-23.1 4041
4 GRAPHIC image.jpg GRAPHIC 4812
5 GRAPHIC image_001.jpg GRAPHIC 1754
6 GRAPHIC img_001.jpg GRAPHIC 11377
7 GRAPHIC img_002.jpg GRAPHIC 29943
  Complete submission text file 0001213900-22-009469.txt   362041
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-252441 | Film No.: 22680036
SIC: 2834 Pharmaceutical Preparations